*The odds ratio presents the odds of using smokeless tobacco among current users compared to never users. **Excluded from the multivariate model because of high collinearity with age.
84 saliva samples were performed for saliva mycobiome analysis using ITS rRNA gene next generation sequencing (NGS), aimed to compare the saliva mycobiome between HIV-infected patients (HIV) and HIV-u
The possibility that smokeless tobacco may contribute to oral carcinogenesis by influencing the oral microbiome has not been explored. This cross sectional study sought to assess the effect use of sha
In the wake of smokeless tobacco (SLT) being advocated as a mean of tobacco harm reduction, it is pertinent to establish individual health risks associated with each SLT product. This case-control stu